Division of Cardiovascular disease, Mayo Clinic Hospital, Phoenix, Arizona, USA.
Department of Medicine, Creighton University, Phoenix, Arizona, USA.
Catheter Cardiovasc Interv. 2024 Oct;104(4):829-836. doi: 10.1002/ccd.31190. Epub 2024 Aug 15.
Despite optimal medical therapy and cardiac resynchronization therapy (CRT), significant functional mitral regurgitation (MR) persisted in 30% of the patients and labeled as CRT nonresponders.
We sought to study the impact of transcatheter edge-to-edge repair (TEER) in patients with symptomatic grade III and IV functional MR despite CRT.
A retrospective analysis was conducted of all patients who had prior CRT for at least 6 months and underwent TEER for significant residual functional MR (grade ≥3) and symptomatic heart failure (HF) at our institution. The primary outcomes were the change in New York Heart Association classification (NYHA), MR grade, echo parameters, and NT-ProBNP from baseline to 1-year post-procedure.
A total of 28 patients were identified, mean age of 73 ± 6.7 years and 89% males. Procedure success was achieved in all patients. At 1-year follow-up, patients had lower MR grade (median 2, IQR 1 [1,2] vs. 4, IQR 1 [3,4]; p < 0.001), NYHA class (median 2, IQR 1 [2,3] vs. 3, IQR 1 [3,4]; p < 0.001), and NT-ProBNP (7658 ± 11322 vs. 3760 ± 4431; p = 0.035) compared to before the TEER procedure. The left ventricular end-diastolic volume (255 ± 59 vs. 244 ± 66 mm; p = 0.016) and the right ventricular systolic pressure (52 ± 14 mmHg vs. 37 ± 13 mmHg, <0.001) decreased.
Patients who remain symptomatic after CRT with severe functional MR had improved functional status and MR grade at 1-year following TEER. There was a signal toward reverse remodeling.
尽管进行了最佳的药物治疗和心脏再同步治疗(CRT),但仍有 30%的患者存在明显的功能性二尖瓣反流(MR),并被标记为 CRT 无反应者。
我们旨在研究经导管缘对缘修复(TEER)在 CRT 后仍有症状性 III 级和 IV 级功能性 MR 的患者中的影响。
对在我院因严重残余功能性 MR(≥3 级)和有症状性心力衰竭(HF)而接受 TEER 治疗的所有至少接受 CRT 治疗 6 个月的患者进行回顾性分析。主要终点是从基线到术后 1 年时纽约心脏协会(NYHA)分级、MR 分级、超声心动图参数和 N 末端脑钠肽前体(NT-ProBNP)的变化。
共确定了 28 例患者,平均年龄为 73±6.7 岁,90%为男性。所有患者均成功完成了手术。在 1 年随访时,患者的 MR 分级(中位数 2,IQR 1 [1,2] vs. 4,IQR 1 [3,4];p<0.001)、NYHA 分级(中位数 2,IQR 1 [2,3] vs. 3,IQR 1 [3,4];p<0.001)和 NT-ProBNP(7658±11322 vs. 3760±4431;p=0.035)均低于 TEER 术前。与 TEER 术前相比,左心室舒张末期容积(255±59 vs. 244±66 mm;p=0.016)和右心室收缩压(52±14 mmHg vs. 37±13 mmHg,p<0.001)降低。
在 CRT 后仍有严重功能性 MR 且有症状的患者在 TEER 后 1 年时,其功能状态和 MR 分级得到改善。存在逆向重构的迹象。